A single-center, open-label, single-arm, phase I study with dose expansion cohort of sacituzumab govitecan in combination with cisplatin for patients with platinum sensitive recurrent ovarian and endometrial cancer.

Authors: Melanie Wain Kier, Erin L. Moshier, Stephanie V. Blank, Monica Prasad Hayes, Jamal Rahaman, Konstantin Zakashansky, Valentin Kolev, Kristen Zeligs, Samantha Cohen, Caitlin Carr, Ana Acuna-villaorduna, Theresa Shao, Dmitriy Zamarin, Amy Tiersten

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps5623

Source: Full article

---

Abstract

TPS5623